Latest Steven Nissen Stories
Speaking before a U.S. advisory panel, Cleveland Clinic cardiologist Steven Nissen said higher standards of testing should be enforced to ensure that new proposed diabetes medicines do not damage patientsâ€™ hearts.
Iowa Senator Charles Grassley said yesterday that Dr. Steven M. Haffner, a well-known diabetes expert at the University of Health Science Center in San Antonio, had leaked confidential, unpublished information to GlaxoSmithKline (GSK) that questioned the safety of the companyâ€™s diabetes drug Avandia.
How can big safety issues go undetected in medicines taken by millions of people for many years, as happened this week with the diabetes pill Avandia and a few years ago with the painkiller Vioxx?
By Ben Hirschler, European Pharmaceuticals Correspondent BARCELONA (Reuters) - The booming market for drug-coated stents faces an uncertain future as some heart experts question the long-term safety record of the devices.
By Susan Heavey WASHINGTON (Reuters) - An experimental diabetes drug that may increase the risk of congestive heart failure and death should not be allowed on the market despite initial support from U.S. regulators, a consumer group said on Monday.
By Andrew Stern CHICAGO (Reuters) - The experimental diabetes drug, Pargluva, made by Merck & Co. Inc. and Bristol-Myers Squibb, may carry risks of heart attack and cancer and should be studied further, researchers said on Thursday. Dr.
CHICAGO (Reuters) - The experimental diabetes drug Pargluva, made by Merck and Co. Inc. and Bristol-Myers Squibb, may carry risks for heart attacks and cancer and should be studied further, researchers said on Thursday.
- An armed gangster.